10-Q: Nortech Systems Reports Mixed Results in Q3 2024 Amidst Inventory Rebalancing and Facility Consolidation

Sentiment:

Quarterly Report


Nortech Systems experienced a decrease in net sales and gross profit for the third quarter of 2024, while also managing facility closures and a credit agreement amendment.

Worse than expectedThe company reported a net loss for the quarter, which is worse than the net income reported in the same period last year.Net sales and gross profit decreased, indicating a decline in business performance compared to the previous year.The company's backlog decreased significantly, suggesting a potential future decline in revenue.

Summary

  • Nortech Systems reported a net loss of $739,000 for the three months ended September 30, 2024, compared to a net income of $1,207,000 for the same period in 2023.
  • Net sales decreased by 5.9% to $31,407,000 for the quarter and 3.6% to $99,513,000 for the nine months ended September 30, 2024.
  • Gross profit decreased to $3,835,000 for the quarter and $13,900,000 for the nine months ended September 30, 2024, down from $5,319,000 and $16,277,000 respectively in the prior year.
  • The company is closing its Blue Earth facility by the end of 2024, incurring restructuring charges of $267,000 for the nine months ended September 30, 2024.
  • A new $15,000,000 Senior Secured Revolving Line of Credit with Bank of America was established in February 2024, replacing the previous agreement.
  • The company had $9,550,000 outstanding on the line of credit as of September 30, 2024, with $5,450,000 of unused availability.
  • The 90-day shipment backlog was $29,631,000 as of September 30, 2024, a decrease of 1.5% from June 30, 2024, and 12.3% from the prior year.
  • Total order backlog was $69,770,000 as of September 30, 2024, a 4.8% decrease from the prior quarter and a 31.8% decrease from the prior year.

Sentiment

Score: 4

Explanation: The document presents a mixed picture with some positive developments like the new credit facility and growth in the aerospace sector, but the overall sentiment is negative due to decreased sales, profitability, and backlog. The restructuring charges and facility closure also add to the negative sentiment.

Positives

  • The company established a new credit facility with Bank of America, providing access to $15,000,000 in financing.
  • The company met the financial covenants of the new credit facility for the period ended September 30, 2024.
  • The company received a waiver for a covenant breach related to operating expenses in Mexico.
  • The company is consolidating its facilities to improve efficiency.
  • Aerospace and defense net sales increased by 23.3% for the nine months ended September 30, 2024.

Negatives

  • The company reported a net loss of $739,000 for the three months ended September 30, 2024.
  • Net sales decreased by 5.9% for the quarter and 3.6% for the nine months ended September 30, 2024.
  • Gross profit decreased by 27.9% for the quarter and 14.6% for the nine months ended September 30, 2024.
  • The company's backlog decreased significantly, indicating reduced future revenue visibility.
  • The company experienced reduced operating leverage due to lower production at some facilities.
  • Industrial net sales decreased by 19.2% for the three months ended September 30, 2024.

Risks

  • The company faces risks related to market volatility, supply chain disruptions, and competition within the EMS industry.
  • The company is exposed to risks related to the loss of major customers and changes in customer ordering practices.
  • The company is subject to risks related to compliance with FDA regulations.
  • The company is exposed to risks related to commodity and energy cost instability.
  • The company is exposed to risks related to cyber-security incidents and natural disasters.
  • The company is exposed to risks related to outbreaks of epidemic, pandemic, or contagious diseases.

Future Outlook

The company expects to complete the closure of its Blue Earth facility by the end of 2024 and anticipates moving several programs for one customer to its Monterrey, Mexico facility in the fourth quarter of 2024. The company also expects to incur approximately $800,000 of cash restructuring costs in 2024.

Management Comments

  • Management noted that the decrease in net sales was primarily due to inventory re-balancing with existing customers, timing of customer product launches, and lower average sales prices.
  • Management stated that the decrease in industrial net sales was due to customers reducing inventory investments and delayed program launches.
  • Management indicated that the increase in aerospace and defense net sales was due to increasing demand and improved supply chain availability.
  • Management mentioned that customers are returning to pre-pandemic ordering practices, resulting in a decrease in backlog.

Industry Context

The company operates in the competitive EMS industry, serving the medical, aerospace and defense, and industrial markets. The results reflect broader trends of inventory rebalancing and supply chain normalization affecting the industry. The company's facility consolidation and credit agreement amendment are strategic moves to adapt to these changes.

Comparison to Industry Standards

  • The decrease in Nortech's gross profit margin to 12.2% for the quarter is below the average for the EMS industry, which typically ranges from 15% to 20%.
  • Companies like Jabil and Flex, which are larger EMS providers, often report higher gross margins due to economies of scale and more diversified customer bases.
  • Nortech's backlog decrease of 31.8% year-over-year is significant and indicates a potential slowdown in future revenue compared to industry peers who have seen more stable backlog levels.
  • The restructuring charges related to the facility closure are similar to actions taken by other EMS companies to optimize their operations and reduce costs.
  • The new credit facility is a common financial strategy for EMS companies to manage working capital and fund growth, but the interest rate of 7.9% is relatively high compared to larger companies with better credit ratings.

Related Party Transactions

  • The company has accounts receivable related to Abilitech Medical, Inc., of which David Kunin, the company's Chairman, is a minority owner.
  • The company has an agreement with Marpe Technologies, LTD, of which David Kunin is a minority owner and board member, to apply for a grant from the BIRD Foundation.

Stakeholder Impact

  • Shareholders may be concerned about the decrease in net sales, profitability, and backlog.
  • Employees at the Blue Earth facility will be affected by the facility closure.
  • Customers may experience changes in lead times and product availability due to facility consolidation and program transfers.
  • Suppliers may be impacted by changes in the company's production volumes and material requirements.
  • Creditors may be concerned about the company's financial performance and ability to meet its obligations.

Next Steps

  • The company plans to complete the closure of its Blue Earth facility by the end of 2024.
  • The company intends to move several programs for one customer to its Monterrey, Mexico facility in the fourth quarter of 2024.
  • The company will continue to monitor and manage its supply chain and customer relationships.

Key Dates

DateDescription
2017-05-31Initial authorization of shares under the 2017 Stock Incentive Plan.
2017-06-15Original credit agreement with Bank of America was entered into.
2020-03-01Additional shares authorized under the 2017 Stock Incentive Plan.
2022-05-01Additional shares authorized under the 2017 Stock Incentive Plan.
2023-05-01Additional shares authorized under the 2017 Stock Incentive Plan.
2024-02-29New $15,000,000 Senior Secured Revolving Line of Credit with Bank of America was established.
2024-05-01Additional shares authorized under the 2017 Stock Incentive Plan.
2024-09-30End of the reporting period for the quarterly report.
2024-11-01Number of shares of common stock outstanding as of this date was 2,756,754.
2024-11-07Date of the quarterly report.

Keywords

contract manufacturing, EMS, medical devices, aerospace, defense, industrial, supply chain, manufacturing, financial results, backlog

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.